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Abstracts of the short communications
Victoria Losinski, Christina Cipolle, University of
Minnesota, St Paul, USA
Realizing the transformation of a profession: the case study
of the State of Minnesota
Aim of project: For over 15 years the pharmacy profession
has been changing from a product to a patient centred
profession with pharmaceutical care as the standard of
practice. These changes have been occurring slowly, but
consistently around the world. In the last year, the State of
Minnesota experienced a rapid increase in the number of
pharmaceutical care practices due to multiple factors. The
aim of this project is to identify these factors and explore
how they have contributed to changing pharmacy practice.
Method: A descriptive analysis of pharmacy practice in
the United States, speciﬁcally in the State of Minnesota,
was completed to identify factors which have led to
increasing numbers of pharmaceutical care practices.
Further analysis was completed to deﬁne how these factors
aided pharmaceutical care practice development in the
State of Minnesota.
Result(s): Three main factors have contributed to
pharmacy’s accelerated transformation: clearly deﬁned
standards of pharmaceutical care practice, accessible web-
based pharmaceutical care training, and commercially
available pharmaceutical care practice planning tools and
resources. Minnesota legislature clearly deﬁned the service
and standards of pharmaceutical care practice for phar-
macists in the State of Minnesota. This created a frame-
work that pharmaceutical care practitioners could clearly
understand and consistently demonstrate each time that
they provide care to a patient. Online pharmaceutical care
training was introduced to prepare pharmacists to provide
pharmaceutical care using the deﬁned standards of practice.
This allowed pharmacists to access training regardless of
their access to a university setting. Finally, practice
development tools including a practice planning guide and
documentation and billing system were made commer-
cially available. These tools have helped pharmaceutical
care practitioners create a vision for their practice and
access the information they need to make it a reality. These
three factors have helped Minnesota pharmacists to
implement viable pharmaceutical care practices across the
state and are currently being used to aid other pharmacists
at a state, national, and international level resulting in a
collective transformation of the pharmacy profession.
Susanne Kaae, Janine Morgall Traulsen, Birthe
Søndergaard, Lotte Stig Haugbølle The Danish
University of Pharmaceutical Sciences, Copenhagen,
Denmark
The ﬁrst Danish publicly reimbursed cognitive service in
community pharmacies on a national scale—why and how
did it become reality?
Aim of project: Contracts for third party reimbursement of
cognitive services in community pharmacies are becoming
increasingly frequent. The aim of this study is to explore
why and how. The driving forces of the two main actors
negotiating on the ﬁrst contract of a publicly reimbursed
cognitive service on a national scale in Danish community
pharmacies—‘‘Check the inhalation’’ will be explored.
‘‘Check the inhalation’’ consists of a 20 min check by the
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using asthma devices.
Method: An analysis of the literature describing the his-
toric and political process leading to‘‘Check the inhalation’’
will be presented. The analysis is based on two different
theoretical approaches: ‘‘a) ‘‘neo-weberian’’ profession
theory—to explain the driving forces of Danish community
pharmacies and b) an approach regarding analysis of poli-
cymaking in the ﬁeld of pharmacy—laid out by Traulsen/
Almarsdottir—to explain the driving forces of Danish
politicians, when negotiating on ‘‘Check the inhalation’’.
Result(s): Since the beginning of the 1990’s, Danish
community pharmacies have made pharmaceutical care
and provision of cognitive services a key survival strat-
egy—as historic monopolies such as producing and dis-
pensing medicines have been deregulated. Many within the
pharmacy sector have recognized that third party payment
essential in order to strengthen permanent implementation
of cognitive services. Policy making in the ﬁeld of medi-
cine including pharmacy, has for the last 5 years, been
dominated by a cost containment view. Danish politicians
have however started recognising, that rational pharmaco-
therapy might be an additional solution to reduce rising
costs on medicine. Danish pharmacies have been active in
political work prior to ‘‘Check the inhalation’’, pressing
forward their argument, that pharmacies could undertake
tasks of rational pharmacotherapy.
Conclusion: ‘‘Check the inhalation’’ became a reality, as
Danish politicians began recognising the economic poten-
tial, community pharmacies have in providing services of
rational pharmacotherapy. Danish community pharmacies
have been politically active in this process, as third party
payment of cognitive services to them, is important as a
survival strategy.
I. Krass
1, C. Delaney
2, S. Glaubitz
3, T. Kanjanarach
1.
(1) Faculty of Pharmacy, Sydney, Australia. (2) St
Vincent’s Hospital Sydney, Australia. (3) University of
Utrecht, the Netherlands
Patient satisfaction with Pharmacy Diabetes Disease State
Management (DSM) Services: validation of an instrument
Aim of project: To develop and validate an instrument to
measure patient satisfaction with Diabetes Disease State
Management services delivered by community pharma-
cists.
Method: The Diabetes Disease State Management
Questionnaire (DDSM-Q) was developed on the basis of 14
in-depth, semi-structured interviews with participants, in
the Pharmacy Diabetes Care Program in New South
Wales
1. The results of the qualitative interviews informed
development of a 32 item questionnaire. The DDSM-Q was
next sent to 165 participants of the pharmacy diabetes care
projects. Principal Components Analysis (PCA) followed
by conﬁrmatory factor analysis (CFA) were used to assess
construct validity and Cronbach’s alpha for internal con-
sistency. Concurrent validity was examined by correlation
between the factor scores and change in HbA1g levels.
Result(s): One hundred and seventeen questionnaires
were returned, a 71.3% response rate. Respondents had a
mean age of 63 years and 60% were male. PCA identiﬁed 4
factors (17 items) contributing to consumer satisfaction and
this was conﬁrmed with CFA (model. ﬁt: X’’191 .68;
df = 115; bootstrap P = 0.130). These were labelled ‘‘im-
pact on diabetes self management’’, ‘‘satisfaction with
improvement in knowledge’’ and ‘‘affect based satisfaction
with the pharmacist’s service’’ and ‘‘performance of the
pharmacist’s service’’ with Cronbach’s alphas of 0.83,
0.80, 0.62 and 0.77, respectively. There was a statistically
signiﬁcant correlation between satisfaction scores and
changes in HbA1g.
Conclusion: The results support the validity and reli-
ability of the DDSM-Q as a measure of patient satisfaction
with pharmacist—delivered DSM services for type 2
diabetes. Further research will be needed to validate the
instrument in different populations.
1. Krass et al. The Pharmacy Diabetes Care Program.
http://lwww.guild.org.au/uublic/researchdocs/2OO2-
518 fr.pdf, last accessed 8/12/06. (Funded by CDHA
under the 3rd Community Pharmacy Agreement).
Mrs. Mirjam E.A.P. Kokenberg, Quality Institute for
Pharmaceutical Care, Kampen, The Netherlands
Best practice polypharmacy: the road from a single project
to a nationwide best practice
Aim of project: The development of a nationwide imple-
mentation of polypharmacy intervention which consists of
optimising pharmacotherapy of an individual multi-drug-
user, by medication review by physician and pharmacist
together.
Method:
– In 1999, 2000 and 2001 QIPC studied the organization,
feasibility the medication changes and the ﬁnancial
outcomes of polypharmacy intervention in three phar-
macies.
– In 2004 a major healthcare insurance company showed
interest in the polypharmacy intervention and ﬁnanced
an implementation study in 14 pharmacies and 31
physicians, performed by QIPC.
– In 2005 the Dutch Ministry of Health nominated the
QIPC polypharmacy intervention (together with the
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QIPC and DGV developed a joint Best Practice Poly-
pharmacy structure. A nationwide web based data
system was developed for registration of the interven-
tions on patient level.
– In 2006 the Dutch Ministry of Health partially subsi-
dized the nationwide implementation of this joint Best
Practice Polypharmacy project by QIPC and DGV. This
Best Practice consists of:
– • Selection of patients
– • Medication review by pharmacist and physician
separately
– • Joint consultations between pharmacist and physi-
cian
– • Evaluation on patient level
– • Monitoring and evaluation of the interventions
– • Continuity of the interventions
– • The pharmacists and physicians are coached by DGV
and QIPC for 9 months.
– In 2007 the implementation will continue.
Result(s):
– The published studies in 1999, 2000 and 2001 showed
that the polypharmacy interventions are feasible and
worthwhile. DRP’s were found and solved, the costs of
medication decreased.
– The study of 2004 (839 patients) shows that in 36% of
the reviewed patients a medication change is necessary;
stopping medication happens most often (44%), fol-
lowed by change in doses (23%), change of medication
(20%) and starting new medication (13%). 35% of the
patients says to feel better after the intervention, 97% of
the patients thinks a periodically performed medication
review very important, 36% of the pharmacists and
physicians thinks their professional working relation
improved.
– In 2006 43 groups of pharmacists and physicians are
now implementing the ‘Best Practice Polypharmacy’,
and preliminary data (315 patients) show that in about
50% of the patients a medication change is necessary.
– In 2007 QIPC and DGV aim at coaching 30 groups
intensively and 200 groups less intensively.
Conclusion: (1) Because of the cooperation between
physician and pharmacist outcomes are achieved which
neither of them could achieve individually. (2) Ready and
easy to use materials, ICT and coaching are necessary to
get pharmacists and physicians starting. (3) Practice is
creative: the intervention still develops while optimal
health care is provided.
*DGV stands for the Dutch Institute for safe use of
medicines
Veerle Foulon
1, S. Sirmoens
1, G. Laekeman
1 and P. de
Witte
2. (1) Research Centre for Pharmaceutical Care
and Pharmaco-economics, K.U.Leuven, Belgium. (2)
Programme Director, Faculty of Pharmaceutical
Sciences, K.U.Leuven, Belgium
A conceptual framework for the implementation of
pharmacy practice research in the education of students at
the K.U.Leuven, Belgium
Aim of project: In consequence of the Bologna declaration
of 1999 and the following reform of the Flemish system of
higher education, a master thesis will be one of the
requirements to obtain the degree of Master in Pharma-
ceutical Care from 2007–2008 onwards. The aim of this
project was to develop a conceptual framework for a
master thesis in pharmaceutical care, along with the design
of an adapted curriculum.
Method: On the basis of a review of recent literature and
an analysis of study programmes of different
European faculties of pharmaceutical sciences, a core
group of staff members formulated objectives for the
Master in Pharmaceutical Care. These objectives, consid-
ering knowledge as well as attitudes and practices, were
discussed in focus groups with community pharmacists,
hospital pharmacists and students. The resulting compe-
tency proﬁles were approved by the faculty council and
faculty members agreed upon the particular competencies
that should be attained in the different courses. For the
master thesis, a concept was worked out that integrates
different aspects of the existing study programme and that
gives students the opportunity to develop research skills.
The major parts are 1) literature review; 2) project work; 3)
pharmacy practice research and 4) writing up the ﬁndings.
Results: The master thesis will be organized for groups
of 6 students, working on a central theme. Every division
of the faculty will supervise one group of students, hence
stimulating the integration of fundamental research and
pharmacy practice. Making an individual review of the
literature, addressing one particular issue of the theme, will
prepare students for discussions and help them to develop
research questions. Project work will bring them in contact
with a professional organization or a pharmaceutical
company. The pharmacy practice research project will be
conducted along with the internship in a community
pharmacy. We strongly believe that this will convince both
students and supervisors of the value of the discipline and
accelerate the implementation of pharmacy practice re-
search in Flanders. Finally, writing a dissertation in which
the ﬁndings are confronted with the literature data will
undoubtedly contribute to the education of critical phar-
macists, aspiring for a greater role in health care.
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123Divaldo Pereira de Lyra Jr., Fabiola Sulpino Vieira,
Manoel Roberto da Cuz Santos, Federal University of
Sergipe, Aracuja, Brazil
Introducing actions to implement Pharmaceutical Care
research in Brazil
Aim of project: To introduce actions to implement Phar-
maceutical Care research in public health care system in
Brazil
Method: In August 2005, Pharmaceutical Assistance
Department (DAF) of Brazilian Health Ministry introduced
National action plan to implement and develop Pharma-
ceutical Care research in public health care system (SUS).
This plan was designed because although there were no
studies about drug-related morbimortality in Brazilian
population, drugs have been identiﬁed as the ﬁrst cause of
intoxication in this country. Thus, the DAF, established a
ﬁnancial funding to support research in SUS, including
Pharmaceutical Care. After this, three events were
organized and ﬁnanced by DAF to promote interchange
between Brazilian and foreigner researchers.
Result(s): Of the 27 proposals submitted to Brazilian
Scientiﬁc Commitee, only 11 projects received ﬁnancial
support of DAF. Nowadays, these projects are being
developed in different settings (hospitals, ambulatories and
community pharmacies) of all Brazilian regions. In March
2006, DAF organized the 1st National Forum of Pharma-
ceutical Care research in SUS with 40 Brazilian researchers
to present the projects approved and to discuss the
importance of these studies to promote the rational medi-
cation use in Brazil. In May 2006, nearly 120 experience
reports of 16 Brazilian states were submitted to Scientiﬁc
Committee of the 1st International Seminar of Pharma-
ceutical Care research in SUS and these reports, 90 were
approved to participate. The researchers had opportunity to
discuss with speakers of Spain, USA, Cuba and Argentina.
Besides, they participated of workshops with pharmacist
practioners and managers of Public Health care system
formulating strategies to implement Pharmaceutical Care
research in SUS. In September 2006 occurred the 1st
Brazilian Symposium of Clinical Pharmacy with presence
of speakers of Australia, New Zealand and Japan. In this
event was discussed the importance of post-graduation in
formation of Pharmaceutical Care researchers and prac-
tioners. Based on the results of these events, DAF jointed a
Group with goal of training to Brazilian pharmacists to
practicing the pharmaceutical care, as well as, to create a
net of researchers to monitor and interchange the knowl-
edge obtained by the projects supported by DAF.
Abstracts of the posters
H. Oller Dolcet, S.I. Benrimoj, F. Fernandez-Llimo.
Faculty of pharmacy, Sydney, Australia
A theoretical framework for the implementation of patient-
oriented pharmacy services using a quality management
system
Aim of project: The aim is to develop a sustainable quality
management system based on the concept of continuous
quality improvement grounded in a rigorous theoretical
framework.
Method: A literature review comprising of a search of
the following journals: ‘‘International Journal for Quality
in Health Care’’, ‘‘Joint Commission Journal of Quality
Improvement’’, ‘‘Quality in Health Care’’ (1980–2005) and
the libraries databases of the University of Sydney and
Barcelona using the terms Quality assurance, Quality
improvement, Quality service, Quality management and
Health Care was undertaken.
Results: Six theoretical frameworks were brought
together to develop a conceptual approach. These frame-
works included the ‘‘Plan-Do-Check and Act’’ cycle
(Shewart, 1920’s), the ‘‘14 Principles’’ (Deming, 1930’s),
the ‘‘Juran Trilogy’’ (Juran, 1940’s), the ‘‘Quality Control
Cycle’’ (Ishikawa, 1940’s), the ‘‘Structure-Process-Out-
come’’ model (Donabedian, 1960’s) and the ‘‘Quality
Management Model’’ (Crosby, 1980’s). The proposed
model comprises of four main stages, with particular
emphasis on practical implementation and the process of
long term sustainability. All stages are cyclically interre-
lated as per the concept of continuous quality improve-
ment.
The system background is an enabling stage where the
required infrastructure is assembled. The system design is
the analysis of both the internal systems and the services
provided as per the international quality standards (ISO,
EFQM & JCI). The third stage is the system implementa-
tion, through the establishment of a quality centre. The
system outcomes are evaluated using behavioural changes,
health care and business impact indicators. Simulated
patient methodology will be used as a surrogate measure to
assess the outcomes as well as implementation criteria. As
the framework has been developed using continuous
quality improvement theory, it is inherently cyclic in
nature. The system can constantly be improved and it will
be the basis for implementing patient-oriented pharmacy
services. The empirical research will be conducted with a
group of Spanish community pharmacies.
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1, Guerreiro M.P., Hughes C., McElnay J.C.
(1) Institute of Health Sciences Egas Moniz, Portugal
Applying the Behavioural Pharmaceutical Care Scale
(BPCS) in Portugal
Aim of project: To evaluate the degree of implementation
of pharmaceutical care in Portugal.
Method: A cross-sectional survey was used to gather
information on the type of services routinely provided by
Portuguese community pharmacists (01-03/2006). Data
were collected through a linguistically adapted and pi-
loted version of the BPCS for Portugal
1,2, comprised of
two sections. Section A characterized the pharmacy
premises, staff and general services. Section B evaluated
services provided to the last patients entering the phar-
macy, referring to a speciﬁc time period, using 34
vignettes grouped in three domains: Direct Patient Care
Activities (DPCA; 17 items; score range = 0–85),
Referral and Consultation Activities (RCA; 8 items;
score range = 8–40) and Instrumental Activities (IA; 7
items; score range = 7–35). These are added up to form
the BPCS score (range = 15–160). All Portuguese phar-
macies received the adapted questionnaire (n = 2805),
aiming for n = 561 (P = 21%; d = 3%; 95%CI). Data
were analyzed for descriptive statistics using SPSS
v.13.0.
Results: A total of 564 pharmacists returned the ques-
tionnaire (20.1%). Within the DPCA Dimension, docu-
mentation activities were rated low, whilst those involving
direct contact with the patient were particularly strong
(DPCA = 30.6 ± 13.9). Within the RCA Dimension, the
worst rated activities involved direct communication with
the GP (RCA = 19.8 ± 5.5). The highest scoring activities
in the IA Dimension were the provision of medical infor-
mation to patients, the double-validation of prescriptions,
and the use of a private counseling area. The lowest scoring
was assessment of patient satisfaction and performance
evaluation (IA = 23.8 ± 3.7). The BPCS overall score in
Portugal was 71.13.
Discussion: Portuguese BPCS score was slightly lower
than those reported for Northern Ireland (=74.1) and
Switzerland (=76.3), suggesting further improvement in the
implementation and dissemination of pharmaceutical care
in Europe.
(1) Odedina & Segal. Behavioral pharmaceutical care
scale for measuring pharmacists’ activities. Am J
Health-Syst Pharm 1996;53:855–65.
(2) Bell, McElnay, Hughes, Woods A. Provision of
pharmaceutical care by community pharmacists in
Northern Ireland. Am J Health-Syst Pharm
1998;55:2009–13.
C. Rossing (crapharmakon.dk), H. Herborg, L.
Sorensen, Pharmakon, Hillerød, Denmark
Adherence problems among type 2-diabetics
Aim of Project: To generate a sample of type 2-diabetics
with a risk of adherence problems for a controlled inter-
vention study. To estimate the frequency of adherence
problems among type 2-diabetics who were willing to
participate in such a project aimed at exploring and
improving safe and effective use of medicines in a Danish
community pharmacy setting.
Method: From the Danish county of Funen, 6 pharma-
cies were included in the project. Potential project patients
were identiﬁed from pharmacy records as patients who
were aged between 18 and 80 years and had reimbursed
prescriptions of anti-diabetics in the period from
01.01.2006 to 30.09.2006. Altogether 2,017 patients were
informed by mail about the project. Patients were included
in the project if they administered their medication them-
selves, gave written consent to participation and returned a
completed questionnaire on medication use, medication
behaviour plus some clinical measures.
Eight criteria were used to categorize patients as having
a risk of adherence problems including: reported elevated
HbAlc (above 6.1%) and/or elevated blood pressure (above
130,180 mmHg) concurrent with the GP’s dissatisfaction
with the value of these clinical measures; deviations in
medication taking behaviour within the previous 2 weeks;
dissatisfaction with the effect of their medicines; experi-
enced problems with their medicines, and poly-pharmacy.
Result(s) and conclusion(s): In total, 315 patients con-
sented to be included in the study. The mean age was
63.3 years, and 19 1 (60.6%) were males. According to the
criteria, 205 responders (65.1%) were categorized as hav-
ing a risk of adherence problems. The most frequent
problems were elevated clinical values (23.1%), deviation
in medication behaviour (37.8%) and polypharmacy
(15.8%) as risk-factors of non-adherence.
Marleen Haems, Kava, Antwerp, Belgium
KAVA-Foldermanagement: a contribution for written
patient information of good quality
Aim of project: Patients are empowered by being informed
about their diseases and about their medicines. On the legal
side the European directive demands that every medicine is
accompanied by a patient insert. These patient leaﬂets have
to meet legal criteria. On the other side many patient
folders about pathologies, drugs, health, ... are developed
from different origin: insurance companies, pharmaceutical
710 Pharm World Sci (2007) 29:706–715
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associations etc.
As a consequence the health care provider (doctor,
pharmacist, ...) can dispose over a very large amount of
written patient information. The quality however is not
always as one should expect and patient leaﬂets used in
daily practice are sometimes of a rather low quality. With
the project ‘‘Folder management’’ we try to offer a tool for
selection of adequate patient information
Method: Leaﬂets are collected by the Folder manage-
ment team and the technical readability is evaluated
according to the criteria of Flesh-Douma. Secondly, cor-
rectness of content, lay out, and usability in daily practice
is evaluated according to determined criteria.
The leaﬂets which respond positively to the evaluation
procedure are communicated to the profession by publi-
cation and by mentioning on a special webpage. Leaﬂets
which do not respond to the criteria are not mentioned.
Evaluation criteria are communicated to third parties, so
that they can be taken into account when new patient
material is made.
Result(s): 54 patient leaﬂets are evaluated so far. 21
passed the test. Written patient information is necessary,
especially in the pharmaceutical care context. However, the
majority of available patient leaﬂets does not meet the
criteria of technical readability, content correctness, layout
and usability as developed in this project. Examining
leaﬂets thoroughly before using them in daily practice is
necessary. But time is very precious in daily pharmacy
practice and little time is spent on the selection and
evaluation of the patient material that will be used. By
consulting the results of the Project Folder management the
pharmacist can easily select appropriate and qualitative
patient leaﬂets for speciﬁc indications without spending too
much time. With our project ‘‘folder management’’ we
hope to offer a service that contributes to a better quality of
written patient information
Lastra CF, Modamio P, Sebarroja L, Casasin T, Mariﬁo
EL. Clinical Pharmacy and Pharmacotherapy Unit.
Faculty of Pharmacy. University of Barcelona. Avda.
Joan XXlll sin. Barcelona (Spain)
EDEMED: a computer tool about Medication Errors and
drug safety for implementation of pharmaceutical care
Aim of project: Medication Errors (ME) are one of the
major aspects that impacts the practice of pharmaceutical
care, currently resulting in the development of actions
directed to their prevention. The objective of the present
communication is to show the results of the notiﬁcation of
ME carried out by pharmacy students from an interactive
program, developed according to the recommendations of
the Bologna Declaration and of the European Higher
Education Space (EHES).
Method: The interactive program that has been designed
is called EDEMED: Errors of Medication, ﬁnanced by the
Agencia de Gesti6 d’ Ajuts Universitaris i de Recerca
(AGAUR) of the Generalitat of Catalonia, which can be
accessed at the following web site: http://www.ub.edulf-
armaciaclinicalprojectes/errors/.
The program is structured in two blocks. The ﬁrst block
is a self-learning procedure module composed of eight
sections through which the student sequentially deepens
the topics of the security of the medications. The second is
a voluntary notiﬁcation system of ME whose objective is to
enable the student to detect possible ME among his or her
relatives, friends, work, etc. Students can introduce this
information in the program, generating a database that be
introduced in the Program of Prevention of Medication
Errors of Catalonia.
Result(s): One hundred and eleven students voluntarily
participated during the second semester of 2006. The total
number of notiﬁcations carried out thus far is 131, of
which, after their analysis and evaluation, 122 were ac-
cepted, averaging one ME per participating student (max-
imum of 6-minimum of 1). Of the errors notiﬁed, 76 did
not arrive at the patient (62.3%). They were detected in
their greater part in community pharmacy (67.2%) and in
primary care health centres (13.1%). The main causes were
prescription errors (32.8%) and validation/dispensing
errors (15.1 %).
Reviewing the results, it can be stated that the utilization
of this educational tool, which is directly related to the
professional pharmaceutical practice, can clearly contribute
to an integration of theory and initiation of investigation,
especially in enhancing the security of patient use of
medications according to the EHES.
Feletto E, Oller Dolcet H, Femandez-Llirnos F, Roberts
A, Benrimoj SI, Faculty of Pharmacy, Sydney,
Australia
An international approach to linking quality systems
and business capabilities to enhance viability and the
implementation of patient orientated services in community
pharmacy
Aim of project: The aim of this research is to develop
sustainable systems for community pharmacy that are
applicable globally across various health care systems,
cultures and pharmaceutical environments. This may
include quality and capabilities systems that facilitate the
implementation of patient orientated services. This
research is being conducted on an international level to
Pharm World Sci (2007) 29:706–715 711
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centric nature of research results.
Method: The research parallels the development of two
research projects—one being conducted in Spain
1 and the
other in Australia
2. Two interdependent literature reviews
were merged. One review focused on continuous quality
improvement in community pharmacy and comprised a
literature search in: ‘‘International Journal for Quality in
Health Care’’, ‘‘Joint Commission Journal of Quality
Improvement’’ and ‘‘Quality in Health Care’’ journals from
1980–2005. Search terms such as quality assurance, quality
improvement, quality service, quality management and
health care were used. The other search analysed literature
from the Medline, IPA, Embase, AB1 Inform and Business
Source Premier databases. Terms such as pharmacy,
management, business model, pharmacy services and
business viability were used, with no date limits applied to
the search.
Result(s): The resulting ﬁgure that will be presented
shows the merger of these two concepts and highlights
business viability as being the overall outcome for com-
munity pharmacy. This ensures that the primary aim of
community pharmacy remains focused on high quality
pharmaceutical care for the population and patients. Busi-
ness viability is not determined solely by ﬁnancial mea-
sures but as a composite of business impact and health care
impact. The combination of these two factors can provide
metrics on a number of levels which could be indicative of
the degree of that pharmacy’s system sophistication.
References
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Feletto E, Dunphy D, Palmer I, Benrimoj SI, Roberts A.
Faculty of Pharmacy, Sydney, Australia
An industry approach to practice change in community
pharmacy
Aim of Project: Advancing the professional role of com-
munity pharmacy is an international trend that is proving to
be challenging for the industry. Effective change should be
implemented at multiple levels of a profession, from
individual pharmacy to industry level. Identifying new
opportunities and understanding how to roll out new
programs are important elements of multifaceted change.
Research was lacking on strategies for industry change in
community pharmacy, as the focus had been on individual
pharmacies. The absence of a systematic approach at this
higher level may be impeding change for individual phar-
macies. The aim, therefore, was to provide a structure and
system for industry change to occur.
Method: Two concurrent studies were conducted to
achieve these aims. One identiﬁed trends through an
extensive literature review relating to future trends in
health. The literature was divided into the following cate-
gories: future certainties, opportunities for pharmacy,
consequences for pharmacy, and consequences for others.
Then areas of particular interest were identiﬁed, classiﬁed
and assessed and the implications for pharmacists and their
relationship with other health care professionals were
outlined. The second part involved consumer forums held
with 68 consumer representatives and 51 semi-structured
interviews with key pharmacy stakeholders.
Result(s): The ﬁndings of the ﬁrst study resulted in the
development of the Characterising Opportunities Filter
(COF). It is a systematic approach to selecting cognitive
pharmacy services in the context of future health care.
Speciﬁcally, COF characterizes the opportunities for
community pharmacy in seven dimensions. The developed
Pharmlnd Wheel presents issues relevant to designing and
implementing a change program for the industry as a
whole. Industry level change is imperative because if
changes are not introduced across the whole industry, the
industry may act as a brake on attempts by pharmacists to
make changes to service delivery in their pharmacies.
Feletto E, Dunphy D, Palmer I, Benrimoj SI, Roberts A,
Faculty of Pharmacy, Sydney, Australia
Practice change in community pharmacy—tools for service
lmplementation
Aim of Project: Practitioners, policy makers and academics
alike have recognized the need for well developed
implementation processes when launching new pharmacy
initiatives. The change management discipline can provide
a systematic approach to introducing cognitive pharmacy
service in community pharmacies. The ‘‘Change Manage-
ment and Community Pharmacy’’ research project was
designed to address some of the issues that arise in change
management in Australia. One of the main project aims
was to develop practical change tools to support commu-
nity pharmacies for service implementation.
Method: The results came from a synthesis of infor-
mation gathered from Australian pharmacies during the
12 month project. The methodologies used include:
712 Pharm World Sci (2007) 29:706–715
123• 10 focus groups (n = 102)
• 24 case studies of community pharmacies
• a quantitative mail survey with 2,022 community
pharmacy owners, response rate of 28.5% (n = 575)
Data were analysed using a systematic social science
content analysis method.
Result(s): Three tools for pharmacy practitioners were
developed: the Pharmacy Viability Matrix, the Pharmacy
Change Readiness Wheel and the Pharmacy Change
Implementation Wheel. The Pharmacy Viability Matrix
presents four different strategic business models for phar-
macy that are deﬁned by their range of products and their
community scope. The Wheels were developed to help
practitioners practically implement changes. The Pharmacy
Change Readiness Wheel is an assessment tool that
quantiﬁes the pharmacy’s preparedness for change. Then,
the Pharmacy Change Implementation Wheel presents a
systematic approach to planning and implementing a
change program for service.
Feletto. E, Roberts, A & Benrimoj SI. Faculty of
Pharmacy, Sydney. Australia
Optimising business viability in Australian community
pharmacies by integrating cognitive pharmacy services
Aim of project: Integrating cognitive pharmacy services
(CPSs), under the umbrella of pharmaceutical care, into
existing pharmacy business models is challenging. Previ-
ous research conducted by Roberts et al, shows that
implementation can be accelerated through a number of
practice change facilitators. In Australia remuneration has
been achieved for some selected CPSs but, alone, does not
guarantee service implementation and the viability of the
community pharmacy. As the role of pharmacists develops
so too should the business models of pharmacy. The aim of
this project is to develop a conceptual model to guide
research on how Australian community pharmacies opti-
mize their business viability within the changing external
environment.
Method: A literature review was conducted, using the
Medline. IPA, Embase, AB1 Inform and Business Source
Premier databases. Terms such as pharmacy, management,
business model, pharmacy services and business viability
were used, with no date limits set for the search. The
conceptual model presented below shows the interdepen-
dent relationships developed from looking within and
outside the pharmacy literature.
Resul t(s): The framework developed shows that sys-
temized management processes could potentially be used
to help pharmacists provide these cognitive pharmacy
services whilst optimising business viability. This includes
highlighting business ﬂexibility capabilities. Additionally,
systemized management processes would be identiﬁed to
achieve a higher level of service orientation through a
sustainable business model. The research planned for this
project will highlight the interdependency of health care
and business impact for pharmacy and how they can be
used to support the implementation of cognitive pharmacy
services. Practical applications for pharmacy practitioners
will also be developed.
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Studies of health promotion and weight control in
Community Pharmacy in the Republic of Ireland
Aim of project: To investigate attitudes and practices of
community pharmacists in the provision of health promo-
tion advice.
Method: Three studies explored health promotion within
community pharmacy.
Five focus groups investigated pharmacist attitudes to
health promotion, and identiﬁed factors which facilitate or
hinder the provision of health promotion advice. Themes
and sub themes were identiﬁed using NVivo Version 2.0.
In a simulated patient study, researcher (BMI 22 kg/m
2
presented at 20 randomly selected urban pharmacies,
seeking advice on weight control. Responses were recorded
on a structured feedback form.
A pilot weight-control programme, enabled pharmacists
to provide accurate, patient-centred information on weight
control in a time-efﬁcient way. This was delivered to
twenty overweight and obese patients over 3 months.
Before and after measurements of weight, BMI and waist
circumference were used as outcome measures.
Results: From the focus groups the main factor identi-
ﬁed as facilitating the delivery of health promotion was the
positive nature of the pharmacist–patient interaction.
Barriers included difﬁcult relationship with other health
professionals, lack of ﬁnance, lack of time and lack of
expertize. Pharmacists expressed a lack of conﬁdence in
organising structured interventions and in providing advice
on sensitive topics, such as weight loss.
The simulated patient study found that the most com-
mon questions asked were about desired weight loss (7/20)
and the period of time over which the weight was to be lost
(6/20). None of the pharmacy personnel asked why the
researcher wished to lose weight and none of them
measured the researcher’s BMI. The health promotion
information provided was general, with little effort made to
tailor the advice for the patient.
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123Twenty patients were recruited to the weight control
programme and 5 dropped out. After three months, statis-
tically signiﬁcant reductions in weight (–3.55 kg), BMI
(–1.36 kg/m
2), waist circumference (–6.29 cm) and per-
centage weight loss (4.15%) (P < 0.002) were achieved.
This work’ provides good insights into the current health
promotional role of community pharmacists and will
inform the development of larger scale studies.
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Provision of pharmaceutical care by Swiss and German
community pharmacists
Aim of project: PCNE initiated a research study across
European countries with the aim to examine and to com-
pare the extent to which pharmaceutical care is being
implemented into routine practice within community
pharmacies. We present preliminary results from Switzer-
land and Germany.
Methods: Postal survey of a German version of the
validated BPCS questionnaire among all pharmacies in the
German speaking part of Switzerland and in 2 different
regions of Germany (Baden-Wu ¨rttemberg, Saxony-An-
halt).
The 64-item questionnaire assessed characteristics of
responding pharmacists and of their pharmacies, in tree
dimensions of pharmaceutical care: Direct patient care
activities, referral and consultation activities and instru-
mental activities (informational support or performance
evaluation).
Response rates of addressed pharmacies were in Swit-
zerland (CH) 48.2% (392 out of 814) in Baden-Wu ¨rttem-
berg (BW) 9.7% (270/2780) and in Saxony-Anhalt (SA)
36.5% (222/608).
Most pharmacies (CH: 77.0%, BW: 75.9%, SA: 86.5%)
have a private consultation area and most of them use a drug
surveillance system to assess prescribed medicines in a drug
history (CH: 99.7%, BW: 100.0%, SA: 99.5%), to check for
potential drug interactions (CH: 97.4%, BW: 100.0%, SA:
100.0%), to document patient health characteristics (CH:
83.8%, BW: 95.2%, SA: 98.2%) and to check for contrain-
dications (CH: 50.5%, BW: 90,7%, SA: 90.4%) Table 1.
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Co-operation and working together (CAWT) campaign to
promote awareness of type 2 diabetes
Aim of project: To improve public awareness of type 2
diabetes in Pharmacies in Northern Ireland (NI) and the
Republic of Ireland (ROI)
Method(s): The campaign ran in the CAWT areas in NI
and ROI during October/November 2005. All Pharmacies
were included and participants attended training. Pharma-
cies received posters, window displays and leaﬂets. Phar-
macists recorded queries about type 2 diabetes in the week
before (no display); during (materials displayed in phar-
macies relating to type 2 diabetes), and after the campaign
(no display). Queries documented included; nature of
-query, demographic information, existing or no diagnosis
of diabetes and the phamacist’s intervention. A follow-up
Pharmacist Satisfaction Survey was administered 10 weeks
post campaign.
Results: Eighty-six community pharmacies in the
CAWT area participated in the project (51% NI/49% ROI)
and 1192 queries were generated throughout the study: 121
(10%) in the pre-campaign period, 894 (75%) during
campaign and 163 (15%) afterwards. Patient-generated and
pharmacist generated-queries increased by 52% and 86%
Table 1 Frequencies of single activities and scores of the original dimensions
When delivering a new prescription for chronic conditions pharmacist reported (freq.
Of activity in %)
Mean scores ± SD and reliability estimates
(Cronbach’s a) range 1–5 (1 = never 5 = always)
to document
therapeutic
objectives
to question what patients
hope to achieve from drug
therapy
to document the
patient’s medical
condition
to check for
drug-related
problems
Direct patient
care activities
Referral and
consultation
activities
Instrumental
activities
CH 4.7% 15.8% 20.8% 85.2% 2.2 ± 0.7 0.797 2.2 ± 0.6 0.740 2.9 ± 0.8 0.673
BW 6.6% 25.9% 16.2% 83.0% 1.9 ± 0.9 0.884 2.5 ± 0.7 0.755 2.7 ± 0.8 0.706
SA 7.7% 23.1% 16.3% 95.5% 2.1 ± 0.9 0.854 2.6 ± 0.7 0.770 2.7 ± 0.8 0.684
The three regions show rather similar results on aggregated activity levels but more differences if one goes into detailed questions. It can be
assumed that the latter provide more insight into differences of the practice of pharmaceutical care in both countries. At the same time they give
important information about how to improve special activities of pharmaceutical care.
714 Pharm World Sci (2007) 29:706–715
123during the campaign. 43% of patient queries came from
diagnosed diabetics, 37% from patients without diagnosed
diabetes and 20% from a family member. Of the pharma-
cist-initiated queries, 58% were with diagnosed diabetics,
27% were with patients without diagnosed diabetes and
15% were with family members. Pharmacists were more
likely to generate a query with a diagnosed diabetic
(P = 0.00). The most common query, from both the patient
and pharmacist perspective related to diet (21% of total). A
few pharmacists (18.8%) reported knowing of at least one
person diagnosed with type 2 Diabetes as a direct result of
the campaign.
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Effect of a centre of excellence for migraine on
Pharmaceutical Care services in a Primary care setting: a
pilot study
Aim of project: In Belgium, a Centre of Excellence (CE)
was created to help pharmacists gain expertize in one or a
few speciﬁc disorders. The ﬁrst CE was established for
migraine in 2006. The centre offers support to pharmacists
willing to provide Pharmaceutical care services for mi-
graine patients.
Method: The aim of this pilot study was to evaluate the
feasibility and the impact of the CE in a community
pharmacy setting. During 3 months, several intervention
tools were evaluated. Pharmacists were asked to evaluate
the medication proﬁle of ﬁve patients. This information
was obtained upon appointment as well as during each visit
to the pharmacy. The quality of life of the patients was
estimated via standardized questionnaires [EQ-5D and the
Migraine Disability Assessment (MIDAS)-test] at the
beginning and at the end of the study. Participating phar-
macists and patients were asked their opinion on the CE via
a questionnaire at the end of the study.
Result(s): Twelve pharmacists and 36 migraine patients
participated in the pilot study. The patients appreciated the
extra guidance and were willing to visit upon appointment.
Comparing the medication proﬁle at the beginning and at
the end of the study showed a decrease in the use of
analgetics and NSAIDs as well as an increase in the use of
gastroprokinetics and triptans. These changes were not
statistically signiﬁcant. However, the use of antiepileptic
drugs increased signiﬁcantly. Five new patients were star-
ted on antiepileptic drugs, 2 of which were referred by the
pharmacist to the general practitioner. The average
MIDAS-score (which scores the intensity of a migraine
attack) decreased signiﬁcantly whereas the average Euro-
Qol score increased signiﬁcantly. A follow-up study
including a control group is necessary to conﬁrm the
positive effects of this ﬁrst CE on the outcome of migraine
patients.
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